Recent Finacing
Recent Raise
DisperSol develops bioavailability-enhanced formulations for poorly soluble drugs using its KinetiSol amorphous solid dispersion and ArmoRx abuse‑deterrent platforms to advance 505(b)(2) products via partnerships and internal pipeline.
